Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Jul 27, 2023

SELL
$53.34 - $63.11 $640,080 - $757,320
-12,000 Reduced 20.69%
46,000 $2.9 Million
Q1 2023

May 09, 2023

BUY
$51.63 - $56.93 $516,300 - $569,300
10,000 Added 20.83%
58,000 $3.3 Million
Q3 2022

Oct 19, 2022

BUY
$49.9 - $57.32 $2.4 Million - $2.75 Million
48,000 New
48,000 $2.51 Million
Q1 2022

May 06, 2022

SELL
$48.27 - $65.25 $1.8 Million - $2.43 Million
-37,253 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$60.19 - $75.29 $1.09 Million - $1.36 Million
18,054 Added 94.04%
37,253 $2.43 Million
Q1 2021

May 10, 2021

SELL
$57.98 - $73.08 $1.73 Million - $2.18 Million
-29,849 Reduced 60.86%
19,199 $1.18 Million
Q4 2020

Feb 10, 2021

SELL
$62.61 - $71.29 $1,001 - $1,140
-16 Reduced 0.03%
49,048 $3.5 Million
Q3 2020

Nov 06, 2020

BUY
$51.39 - $72.41 $408,396 - $575,442
7,947 Added 19.33%
49,064 $3.41 Million
Q2 2020

Aug 10, 2020

BUY
$39.55 - $54.65 $202,377 - $279,644
5,117 Added 14.21%
41,117 $2.18 Million
Q1 2020

May 12, 2020

BUY
$34.75 - $45.85 $1.25 Million - $1.65 Million
36,000 New
36,000 $1.45 Million
Q4 2019

Feb 06, 2020

SELL
$36.66 - $41.78 $521,415 - $594,236
-14,223 Closed
0 $0
Q2 2019

Aug 12, 2019

SELL
$36.05 - $42.76 $2.52 Million - $2.99 Million
-70,000 Reduced 83.11%
14,223 $533,000
Q4 2018

Feb 08, 2019

BUY
$31.89 - $38.44 $797,250 - $961,000
25,000 Added 42.21%
84,223 $3.18 Million
Q3 2018

Nov 13, 2018

BUY
$29.25 - $36.73 $1.32 Million - $1.65 Million
45,000 Added 316.39%
59,223 $2.05 Million
Q3 2017

Nov 14, 2017

SELL
$30.11 - $37.72 $2.41 Million - $3.03 Million
-80,200 Reduced 84.94%
14,223 $507,000
Q2 2017

Aug 07, 2017

BUY
N/A
94,423
94,423 $3.98 Million

Others Institutions Holding RDY

About DR REDDYS LABORATORIES LTD


  • Ticker RDY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 166,028,992
  • Market Cap $2.55B
  • Description
  • Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...
More about RDY
Track This Portfolio

Track Gam Holding Ag Portfolio

Follow Gam Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gam Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Gam Holding Ag with notifications on news.